Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity (Tables)

v3.22.0.1
Stockholders' equity (Tables)
6 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of warrants or rights
     Common
Stock
from
Warrants
     Weighted-
average
Exercise
Price
(per
share)
 
Outstanding at July 1, 2021
     107,095      $ 10.50  
    
 
 
    
 
 
 
Outstanding and exercisable at December 31, 2021
     107,095      $ 10.50  
Schedule of equity awards
     Stock
Options
     Weighted-
average
Exercise
Price
     Weighted-
average
Remaining
Contractual
Term
     Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2021
     702,064      $ 7.16        8.07 years      $ —    
    
 
 
    
 
 
                   
Outstanding at September 30, 2021
     702,064     
7.16        7.82 years      $ —    
Granted
     36,000        2.99        9.93 years      $ —    
    
 
 
    
 
 
                   
Outstanding at December 31, 2021
     738,064        6.95        7.68 years      $ —    
Exercisable at December 31, 2021
     229,333      $ 13.59        7.20 years      $ —    
    
 
 
    
 
 
                   
Schedule of share-basedcompensation expense
    
Three Months Ended
December 31,
    
Six Months Ended
December 31,
 
(US$’000)   
2021
    
2020
    
2021
    
2020
 
Research and development
   $ 80      $ 6      $ 161      $ 15  
General and administrative
     159        76        349        105  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total share-based compensation expense
   $ 239      $ 82      $ 510      $ 120